Ontology highlight
ABSTRACT:
SUBMITTER: Tewari KS
PROVIDER: S-EPMC4896296 | biostudies-literature | 2015 Dec
REPOSITORIES: biostudies-literature
Tewari Krishnansu S KS Sill Michael W MW Monk Bradley J BJ Penson Richard T RT Long Harry J HJ Poveda Andrés A Landrum Lisa M LM Leitao Mario M MM Brown Jubilee J Reid Thomas J A TJ Michael Helen E HE Moore David H DH
Clinical cancer research : an official journal of the American Association for Cancer Research 20151201 24
<h4>Purpose</h4>In the randomized phase III trial, Gynecologic Oncology Group (GOG) protocol 240, the incorporation of bevacizumab with chemotherapy significantly increased overall survival (OS) in women with advanced cervical cancer. A major objective of GOG-240 was to prospectively analyze previously identified pooled clinical prognostic factors known as the Moore criteria.<h4>Experimental design</h4>Potential negative factors included black race, performance status 1, pelvic disease, prior ci ...[more]